Related Experiment Video
Updated: May 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS FOR EARLY DETECTION OF CHRONIC DISEASES: A SYSTEMATIC REVIEW
E Manzhalii1, Y Dekhtiar2, V Bannikov3
11Doctor of Medical Science, Professor, Professor of the Department of Propedeutics of Internal Medicine at the Bogomolets Medical University, Kyiv, Ukraine.
Introduction:
Early detection of chronic diseases is critical for reducing morbidity and alleviating the overall healthcare burden. Artificial intelligence (AI) has emerged as a promising tool for enhancing diagnostic accuracy, risk prediction, and clinical decision support. This review synthesizes recent evidence on AI-driven diagnostic systems across diverse chronic diseases.
Methods:
A systematic review was conducted following the PRISMA guidelines. Peer-reviewed English-language studies published between January 2020 and November 2025 were retrieved from PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, and Embase.
Results:
Thirty-two studies from 13 countries were included, with most originating from China, India, and Saudi Arabia. The studies examined metabolic/cardiometabolic conditions (20 studies), musculoskeletal disorders (3), pulmonary diseases (3), cancer/hematological conditions (3), neurodegenerative diseases (1), and ophthalmologic/dental conditions (2). Hybrid AI models were the most commonly used overall (56%), especially in metabolic diseases, followed by machine learning (25%) and deep learning (19%). Validation approaches included k-fold cross-validation, 80/20 train-test splits, electronic health record (EHR)-based validation, and external validation. Across subgroups, predictive performance was high, with AUC ranging from 0.7467 to 1.0, accuracy from 77.08% to 99.97%, sensitivity from 77% to 100%, and specificity from 59.2% to 100%.
Discussion:
AI models, particularly hybrid approaches, demonstrate potential for early detection of chronic diseases by integrating laboratory, clinical, and imaging-based multimodal data. However, heterogeneity in datasets, retrospective study designs, limited external validation, and inconsistent reporting constrain generalizability. These findings highlight the need for prospective multicenter trials, standardized datasets, and improved methodological transparency to support clinical implementation.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Automated Microbial Diagnostics

